TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts21212626
Avg. Estimate1.061.114.243.8
Low Estimate0.940.853.993.04
High Estimate1.21.314.564.96
Year Ago EPS1.311.385.144.24
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts19192424
Avg. Estimate5.63B5.75B22.68B21.43B
Low Estimate5.52B5.2B22.24B20.04B
High Estimate5.76B6.05B22.99B23.38B
Year Ago Sales5.56B6.49B21.9B22.68B
Sales Growth (year/est)1.20%-11.40%3.60%-5.50%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.1.281.351.031.06
EPS Actual1.311.381.061.02
Difference0.030.030.03-0.04
Surprise %2.30%2.20%2.90%-3.80%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate1.061.114.243.8
7 Days Ago1.071.124.263.85
30 Days Ago1.071.184.324.01
60 Days Ago1.071.184.324.02
90 Days Ago1.251.44.754.7
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 Days11N/AN/A
Up Last 30 Days21N/AN/A
Down Last 30 Days2344
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesTEVAIndustrySectorS&P 500
Current Qtr.-19.10%N/AN/A0.15
Next Qtr.-19.60%N/AN/A0.27
Current Year-17.50%N/AN/A0.07
Next Year-10.40%N/AN/A0.12
Next 5 Years (per annum)-6.90%N/AN/A0.10
Past 5 Years (per annum)-1.21%N/AN/AN/A